CONTAINER PRECURSOR HAVING A WALL OF GLASS WHICH IS SUPERIMPOSED BY A PLURALITY OF PARTICLES
Container precursors are provided that have a wall of glass. The wall of glass at least partially encloses an interior volume. The wall of glass has a side that faces away from the interior volume. The side is at least partially superimposed by a plurality of particles. An arrangement is also provided that includes a packaging and a multitude of the container precursors. A process for preparing a functionalised container precursor is also provided. A process for packaging pharmaceutical compositions and closed containers obtainable by this process are provided.
1 . A container precursor comprising:
a wall of glass at least partially enclosing an interior volume; and
a plurality of particles at least partially superimposing a side of the wall of glass that faces away from the interior volume.
2 . The container precursor of claim 1 , wherein the plurality of particles superimposes at least 10% of the side of the wall of glass that faces away from the interior volume.
3 . The container precursor of claim 1 , wherein the plurality of particles superimposes 1 to 50% of the side of the wall of glass that faces away from the interior volume.
4 . The container precursor of claim 1 , wherein the side of the wall of glass that faces away from the interior volume has a coefficient of dry sliding friction of less than 0.25.
5 . The container precursor of claim 1 , wherein the plurality of particles is across between at least 10% and a full surface area of the side of the wall of glass that faces away from the interior volume.
6 . The container precursor of claim 1 , wherein the side of the wall of glass that faces away from the interior volume has a contact angle for wetting with water of 0 to 45°.
7 . The container precursor of claim 1 , wherein the wall of glass comprises a side that faces the interior volume that is not superimposed by any of the plurality of particles.
8 . A container comprising:
a wall of glass that forms a hollow glass body at least partially enclosing an interior volume, wherein the hollow glass body comprises, in a direction of a length of the hollow glass body, a first end region, a body region, and a further end region;
a plurality of particles at least partially superimposing a side of the wall of glass that faces away from the interior volume in the body region,
wherein, in the first end region and/or in the further end region, the side of the wall of glass that faces away from the interior volume is not superimposed by any of the plurality of particles.
9 . The container of claim 8 , wherein the body region has a first coefficient of dry sliding friction at the side of the wall of glass that faces away from the interior volume, the first end region has a second coefficient of static friction, and the further end region has a third coefficient of static friction, the container further comprising a ratio of the first coefficient of dry sliding friction to the second coefficient of static friction and/or to the third coefficient of static friction in a range from 0.01 to 0.9; and
wherein the second and/or third coefficient of static friction is at least 0.15.
10 . The container of claim 8 , further comprising a closure closing the interior volume and a pharmaceutical composition in the interior volume.
11 . The container of claim 8 , wherein the particles of the plurality of particles are directly joined to the wall of glass via Van-der-Waals forces, but not via covalent bonds.
12 . The container of claim 8 , wherein the wall of glass comprises a side that faces the interior volume that is not superimposed by any of the plurality of particles.
13 . The container of claim 8 , wherein the plurality of particles comprise a particle size distribution selected from a group consisting of a D 50 in a range from 1 to 100 μm, a D 10 in a range from 0.1 to 50 μm, a D 90 in a range from 0.5 to 100 μm, a full width at half maximum (FWHM) which is less than 30%, and combinations thereof.
14 . The container of claim 8 , wherein the plurality of particles have a decomposition temperature of between more than 500° C. and 2,000° C.
15 . The container of claim 14 , wherein the decomposition temperature is more than 1,400° C.
16 . The container of claim 8 , wherein the plurality of particles comprise a material selected from a group consisting of a boron nitride, a molybdenum sulphide, a silicon nitride, an oxide, MoS 2 , Si 3 N 4 , silicon oxide, titanium oxide, SiO 2 , TiO 2 , siloxane, a silane, organo-silane, latex, silicone resin, hybridpolymer silane, a hybridpolymer siloxane, polyorganosiloxane, polyalkylsiloxane, polysilsesquioxane, inorganic silane,
17 . The container of claim 8 , wherein the particles of the plurality of particles are not embedded in any material.
18 . The container of claim 8 , wherein the plurality of particles have an aspect ratio in a range from 0.5 to 1.5.
19 . The container of claim 8 , wherein the wall of glass has a transmission of light of a wavelength in a range from 400 nm to 2300 nm of more than 0.7.
20 . An arrangement comprising:
a packaging; and
a plurality of containers of claim 8 packaged in the packaging.
21 . A process for preparing a functionalised container precursor, comprising:
providing a wall of glass that at least partially encloses an interior volume;
superimposing at least a part of the wall of glass on a side of the wall of glass that faces away from the interior volume with a composition, the composition comprising a first plurality of particles and a vehicle; and
decreasing a proportion of the vehicle in the composition, thereby leaving the first plurality of particles and/or particles obtained from the first plurality of particles superimposed on the wall of glass.